Design and development of TT30, a novel C3d-targeted C3/C5 convertase inhibitor for treatment of human complement alternative pathway-mediated diseases / Fridkis Hareli, M., Storek, M., Mazsaroff, I., Risitano, A.M., Lundberg, A.s., Horvath, C.j., Holers, V.M.. - In: BLOOD. - ISSN 0006-4971. - STAMPA. - 118:(2011), pp. 4705-4713.
Design and development of TT30, a novel C3d-targeted C3/C5 convertase inhibitor for treatment of human complement alternative pathway-mediated diseases.
RISITANO, ANTONIO MARIA;
2011
File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
